Zynerba Pharmaceuticals, Inc. – LSE:0M40.L
Zynerba Pharmaceuticals stock price today
Zynerba Pharmaceuticals stock price quarterly change
Zynerba Pharmaceuticals stock price yearly change
Zynerba Pharmaceuticals key metrics
Market Cap | 49.02M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.78 |
Revenue | N/A |
EBITDA | -38.28M |
Income | -37.00M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeZynerba Pharmaceuticals stock price history
Zynerba Pharmaceuticals stock forecast
Zynerba Pharmaceuticals financial statements
| Sep 2022 | 0 | -8.85M | |
|---|---|---|---|
| Dec 2022 | 0 | -7.61M | |
| Mar 2023 | 0 | -9.75M | |
| Jun 2023 | 0 | -10.77M |
| Sep 2019 | 94317230 | 9.30M | 9.86% |
|---|---|---|---|
| Dec 2019 | 87764596 | 12.16M | 13.86% |
| Mar 2023 | 48636533 | 9.66M | 19.88% |
| Jun 2023 | 40476561 | 11.45M | 28.3% |
| Sep 2022 | -9.65M | -95.09K | 3.19M |
|---|---|---|---|
| Dec 2022 | -5.68M | -7.4K | 399.35K |
| Mar 2023 | -7.88M | -89.55K | 1.72M |
| Jun 2023 | -8.41M | -8.39K | -6.70K |
Zynerba Pharmaceuticals alternative data
| Aug 2023 | 25 |
|---|---|
| Sep 2023 | 25 |
| Oct 2023 | 25 |
| Nov 2023 | 25 |
| Dec 2023 | 25 |
| Jan 2024 | 25 |
| Feb 2024 | 25 |
| Mar 2024 | 25 |
| Apr 2024 | 25 |
| May 2024 | 25 |
| Jun 2024 | 25 |
| Jul 2024 | 25 |
Zynerba Pharmaceuticals other data
| Insider | Compensation |
|---|---|
Mr. Armando Anido M.B.A., MBA (1958) Chairman & Chief Executive Officer | $956,420 |
| Ms. Terri B. Sebree (1958) Pres | $715,880 |
| Mr. James E. Fickenscher (1964) Chief Financial Officer, Vice President of Corporation Devel. & Treasurer | $596,620 |
Mr. William C. Roberts Vice President of Investor Relations & Corporation Communications | |
| Ms. Suzanne M. Hanlon Sec., Vice President & Gen. Counsel | |
Dr. Joseph Palumbo Chief Medical Officer |
-
What's the price of Zynerba Pharmaceuticals stock today?
One share of Zynerba Pharmaceuticals stock can currently be purchased for approximately $3.04.
-
When is Zynerba Pharmaceuticals's next earnings date?
Unfortunately, Zynerba Pharmaceuticals's (0M40.L) next earnings date is currently unknown.
-
Does Zynerba Pharmaceuticals pay dividends?
No, Zynerba Pharmaceuticals does not pay dividends.
-
How much money does Zynerba Pharmaceuticals make?
Zynerba Pharmaceuticals has a market capitalization of 49.02M.
-
What is Zynerba Pharmaceuticals's stock symbol?
Zynerba Pharmaceuticals, Inc. is traded on the LSE under the ticker symbol "0M40.L".
-
What is Zynerba Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Medical - Pharmaceuticals industry.
-
How do i buy shares of Zynerba Pharmaceuticals?
Shares of Zynerba Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Zynerba Pharmaceuticals's key executives?
Zynerba Pharmaceuticals's management team includes the following people:
- Mr. Armando Anido M.B.A., MBA Chairman & Chief Executive Officer(age: 67, pay: $956,420)
- Ms. Terri B. Sebree Pres(age: 67, pay: $715,880)
- Mr. James E. Fickenscher Chief Financial Officer, Vice President of Corporation Devel. & Treasurer(age: 61, pay: $596,620)
- Mr. William C. Roberts Vice President of Investor Relations & Corporation Communications
- Ms. Suzanne M. Hanlon Sec., Vice President & Gen. Counsel
- Dr. Joseph Palumbo Chief Medical Officer
-
How many employees does Zynerba Pharmaceuticals have?
As Jul 2024, Zynerba Pharmaceuticals employs 25 workers.
-
When Zynerba Pharmaceuticals went public?
Zynerba Pharmaceuticals, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Zynerba Pharmaceuticals's official website?
The official website for Zynerba Pharmaceuticals is zynerba.com.
-
Where are Zynerba Pharmaceuticals's headquarters?
Zynerba Pharmaceuticals is headquartered at 80 West Lancaster Avenue, Devon, PA.
-
How can i contact Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals's mailing address is 80 West Lancaster Avenue, Devon, PA and company can be reached via phone at +48 45817505.
Zynerba Pharmaceuticals company profile:
Zynerba Pharmaceuticals, Inc.
zynerba.comLSE
25
Medical - Pharmaceuticals
Healthcare
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. The company was formerly known as AllTranz, Inc. and changed its name to Zynerba Pharmaceuticals, Inc. in August 2014. Zynerba Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania.
Devon, PA 19333
:
:
:
